Brought to you by 
Late-stage round generates $36.2mm for DFine
19 Aug 2010
Executive Summary
DFine Inc. (developing minimally invasive devices for vertebral fractures) has brought in $36.2mm through a late-stage financing led by first-time Split Rock Partners. Fellow new backer OrbiMed, returning shareholders Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, and Highland Capital Management, and private investors also participated. A member of Split Rock and OrbiMed will join the company's board. The funds will be used for ongoing commercialization of its StabiliT vertebral augmentation system.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Late-stage round generates $36.2mm for DFine
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice